Alphenal
From Wikipedia, the free encyclopedia
 |
|
|
Alphenal
|
|
| Systematic (IUPAC) name | |
| 5-phenyl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C13H12N2O3 |
| Mol. mass | 244.246 g/mol |
| SMILES | & |
| Synonyms | 5-Phenyl-5-allylbarbituric acid |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
?(US) |
| Routes | Oral |
Alphenal is a barbiturate derivative invented in the 1960s. It has primarily anticonvulsant properties, and was used occasionally for the treatment of epilepsy or convulsions, although not as commonly as better known barbiturates such as phenobarbital. [1]
LD50: Mouse (Oral): 280 mg/kg
[edit] References
- ^ Carissimi M, Nuovi Barbiturici Alogenati. Farmaco. Ediozione scientifica. 17(6):390-413. (1962).
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||
